Hassani Mahdieh, Soleimani Maryam, Esmaeilzadeh Emran, Zare-Abdollahi Davood, Khorram Khorshid Hamid Reza
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Department of Basic Sciences, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Iran J Pharm Res. 2020 Fall;19(4):321-329. doi: 10.22037/ijpr.2020.113808.14505.
The present study was designed to primarily examine the therapeutic potential of the herbal extract of for the treatment of multiple sclerosis in the experimental autoimmune encephalomyelitis (EAE) model of the disease. The animal model was induced in C57BL/6 female mice, and then the herbal extract was intraperitoneally administered for a total of 21 days after the first day of post-immunization. The phenotypic signs, a gene expression profile of inflammatory cytokines, antioxidant state, and pathological hallmarks of the disease in the corpus callosum were evaluated. The prophylactic administration of attenuates the clinical signs of the disease. It significantly declined the gene expression of pro-inflammatory cytokines like IL-6, TNF-α, and IFN-γ. This herbal extract also surged the gene expression, as an anti-inflammatory cytokine. The gene expression of Glutathione peroxidase and Catalase (antioxidant enzymes) was meaningfully higher in the treatment group. Pathological evaluation of corpus callosum cross-sections by Luxol Fast Blue staining revealed preserved myelin sheath in the treated group compared to the EAE mice. The results of our assay confirmed that immunomodulatory and antioxidant features of the herbal extract of ameliorated the EAE severity. This study finding disclosed the therapeutic efficiency of this compound in MS treatment.
本研究旨在主要考察[草药名称]的草药提取物在实验性自身免疫性脑脊髓炎(EAE)疾病模型中治疗多发性硬化症的潜力。在C57BL/6雌性小鼠中诱导建立动物模型,然后在免疫后第一天起腹腔注射该草药提取物,共注射21天。评估了疾病的表型体征、炎性细胞因子的基因表达谱、抗氧化状态以及胼胝体中的疾病病理特征。[草药名称]的预防性给药减轻了疾病的临床症状。它显著降低了促炎细胞因子如IL-6、TNF-α和IFN-γ的基因表达。这种草药提取物还增加了作为抗炎细胞因子的基因表达。治疗组中谷胱甘肽过氧化物酶和过氧化氢酶(抗氧化酶)的基因表达明显更高。通过Luxol Fast Blue染色对胼胝体横截面进行病理评估发现,与EAE小鼠相比,治疗组的髓鞘得以保留。我们的检测结果证实,[草药名称]的草药提取物的免疫调节和抗氧化特性改善了EAE的严重程度。本研究结果揭示了该化合物在多发性硬化症治疗中的治疗效果。